Compounds > 3,4-dihydroxybenzylamine
Page last updated: 2024-08-26

3,4-dihydroxybenzylamine and B16 Melanoma

3,4-dihydroxybenzylamine has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FitzGerald, GB; Prezioso, JA; Wick, MM1
FitzGerald, GB; Wick, MM1

Other Studies

2 other study(ies) available for 3,4-dihydroxybenzylamine and B16 Melanoma

ArticleYear
Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
    The Journal of investigative dermatology, 1992, Volume: 99, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Dopamine; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melanoma; Melanoma, Experimental; Melphalan; Methionine Sulfoximine; Mice; Tumor Cells, Cultured

1992
Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma.
    The Journal of investigative dermatology, 1987, Volume: 88, Issue:1

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Deoxyuracil Nucleotides; Depression, Chemical; DNA Replication; Dopamine; Floxuridine; Humans; Hydroxyurea; Leukemia L1210; Melanoma, Experimental; Methotrexate; Neoplasm Proteins; Thymidylate Synthase

1987